David G Hicks
7PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 16, 2026
Postradiation angiosarcoma of the breast: a 25-year single-institution analysis of clinicopathological characteristics and immunohistochemical biomarker study.Kristin J Rybski, Brian S Finkelman, Bin Zhang
|Sep 11, 2024
Optimized biomarker evaluation and molecular testing in the era of breast cancer precision medicine.David G Hicks, Bradley M Turner
|Feb 11, 2023
The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing.Bradley M Turner, Brian S Finkelman, David G Hicks
|Feb 11, 2023
The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations.Brian S Finkelman, Huina Zhang, David G Hicks
|Feb 20, 2022
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles.Huina Zhang, Hani Katerji, Bradley M Turner
|Jun 15, 2019
Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX® recurrence score <26.Bradley M Turner, Mary Ann Gimenez-Sanders, Armen Soukiazian
Pageof 2
